Also known as: Invasive breast carcinoma / Invasive carcinoma of breast / Breast cancer invasive NOS
DrugDrug NameDrug Description
DB00675TamoxifenOne of the selective estrogen receptor modulators (SERM) with tissue-specific activities for the treatment and prevention of estrogen receptor positive breast cancer. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the endometrium. [PubChem]
DrugDrug NamePhaseStatusCount
DB01217Anastrozole1Active Not Recruiting1
DB00947Fulvestrant1Active Not Recruiting1
DB06186Ipilimumab1Recruiting1
DB01259Lapatinib1Active Not Recruiting1
DB06132Nivolumab1Recruiting1
DB09035Nivolumab1Recruiting1
DB00072Trastuzumab1Active Not Recruiting1
DB00169Cholecalciferol1 / 2Not Yet Recruiting1
DB01006Letrozole1 / 2Not Yet Recruiting1
DB01229Paclitaxel1 / 2Recruiting1
DB09073Palbociclib1 / 2Not Yet Recruiting1
DB05220Alisertib2Not Yet Recruiting1
DB11595Atezolizumab2Not Yet Recruiting1
DB01101Capecitabine2Terminated1
DB00958Carboplatin2Completed1
DB00958Carboplatin2Not Yet Recruiting1
DB00531Cyclophosphamide2Completed1
DB00947Fulvestrant2Not Yet Recruiting1
DB01259Lapatinib2Recruiting1
DB01229Paclitaxel2Not Yet Recruiting1
DB04572Thiotepa2Completed1
DB08911Trametinib2Active Not Recruiting1
DB01217Anastrozole3Recruiting1
DB01101Capecitabine3Recruiting1
DB00958Carboplatin3Recruiting1
DB00515Cisplatin3Recruiting1
DB00990Exemestane3Recruiting1
DB01006Letrozole3Recruiting1
DB09037Pembrolizumab3Recruiting1
DB00675Tamoxifen3Recruiting1